1. Papalois A, Smyrniotis V, Papadimitriou L, Kostopanagiotou G, Vassiliou P, Loukakos P, Lykoudis E, Demonakou M, Pyrsopoulos N, Vagena M, Syriou V, Papadimitriou J, Tolis G. Isolated pancreatic graft of swine: development of a model for drug studies. Transplant Proc 1999 Nov;31(7):2768-71 – PMID 10578285

  2. Pyrsopoulos NT, Reddy K. Extrahepatic manifestations of chronic viral hepatitis. Curr Gastroenterol Rep 2001 Feb;3(1):71-8 – PMID 11177698

  3. Theodoraki K, Kostopanagiotou G, Smyrniotis V, Arkadopoulos N, Prachalias A, Pyrsopoulos N, Papadimitriou J. Haemodynamic changes in ischaemic vs. anhepatic pig experimental model of acute liver failure. Eur J Anaesthesiol 2002 Jan;19(1):40-6 – PMID 11913802

  4. Jeffers L, Chalasani N, Balart L, Pyrsopoulos N, Erhardtsen E. Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy. Gastroenterology 2002 Jul;123(1):118-26 – PMID 12105840

  5. Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, Feng ZZ, Reddy KR, Schiff ER. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002 Oct;97(10):2614-8. – PMID 12385448

  6. Young SA, Sfakianakis GN, Pyrsopoulos N, Nishida S. Hepatobiliary scintigraphy in liver transplant patients: the "blind end sign" and its differentiation from bile leak. Clin Nucl Med. 2003 Aug;28(8):638-42. – PMID 12897647

  7. Pyrsopoulos N., Jeffers L. Chronic hepatitis C in African Americans. Clinics in Liver Disease 2005 Aug;9(3):427-38. – PMID 16023975

  8. Gaynor JJ, Moon JI, Kato T, Nishida S, Selvaggi G, Levi DM, Island ER, Pyrsopoulos N, Weppler D, Ganz S, Ruiz P, Tzakis AG. A cause-specific hazard rate analysis of prognostic factors among 877 adults who received primary orthotopic liver transplantation. Transplantation. 2007 Jul 27; 84(2):155-65. – PMID 17667806

  9. Shariatmadar S, Pyrsopoulos NT, Vincek V, Noto TA, Tzakis AG. Alloimmunization to red cell antigens in liver and multivisceral transplant patients. Transplantation. 2007 Aug 27; 84(4):527- 31. – PMID 17713438

  10. Schreibman I, Gaynor JJ, Jayaweera D, Pyrsopoulos N, Weppler D, Tzakis A, Schiff ER, Regev 1Outcomes after orthotopic liver transplantation in 15 HIV-infected patients. Transplantation. 2007 Sep 27; 84(6):697-705 – PMID 17893602

  11. Kato T, Gaynor JJ, Yoshida H, Montalvano M, Takahashi H, Pyrsopoulos N, Nishida S, Moon J, Selvaggi G, Levi D, Ruiz P, Schiff E, Tzakis A. Randomized trial of steroid-free induction versus corticosteroid maintenance among orthotopic liver transplant recipients with hepatitis C virus: impact on hepatic fibrosis progression at one year. Transplantation. 2007 Oct 15; 84(7):829-35. – PMID 17984834

  12. Taffaro M, Pyrsopoulos N, Cedron H, Cacayorin E, Weppler D, Moon J, Nishida S, Levi D, Kato T, Selvaggi G, Tzakis A, Schiff E.Vitiligo improvement in a hepatitis C patient after treatment with PEG-interferon alpha-2a and ribavirin: a case report. Dig Dis Sci. 2007 Dec;52(12):3435-7. Epub 2007 Apr 12.  PMID:17431776

  13. Pyrsopoulos N., Jeffers L. Hepatitis C in African Americans. J Clin Gastroenterol. 2007 Feb;41(2):185-93. – PMID 17245218

  14. Kostopanagiotou G, Sidiropoulou T, Pyrsopoulos N, Pretto EA Jr, Pandazi A, Matsota P, Arkadopoulos N, Smyrniotis V, Tzakis AG Anesthetic and perioperative management of intestinal and multivisceral allograft recipient in nontransplant surgery. Transpl Int. 2008 Jan 14, May;21(5):415-27. – PMID 18208418

  15. Tuteja S, Pyrsopoulos NT, Wolowich WR, Khanmoradi K, Levi DM, Selvaggi G, Weisbaum G, Tzakis AG, Schiff ER.Simvastatin-ezetimibe-induced hepatic failure necessitating liver transplantation. Pharmacotherapy. 2008 Sep;28(9):1188-93. doi: 10.1592/phco.28.9.1188. - PMID:18752389

  16. Patel T, Nystrom J, Pyrsopoulos N. Autoimmune hepatitis as a part of polyglandular autoimmune syndrome type II: case report and literature review.Dig Dis Sci. 2010 Mar;55(3):861-4. doi: 10.1007/s10620-009-0796-2. Epub 2009 May 7. Review. No abstract available. - PMID:19421855

  17. Wong F, Watson H, Gerbes A, Vilstrup H, Badalamenti S, Bernardi M, Ginès P; Satavaptan Investigators Group Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity. Gut. 2012 Jan;61(1):108-16 – PMID 21836029

  18. Demyen M, Alkhalloufi K, Pyrsopoulos NT. Lipid-lowering agents and hepatotoxicity. Clin Liver Dis. 2013 Nov;17(4):699-714 – PMID 24099026

  19. Pyrsopoulos NT. The art and science of medicine is evolving along with technology. Preface. Clin Liver Dis. 2013 Nov;17(4):xiii-xiv. doi: 10.1016/j.cld.2013.09.013. No abstract available. - PMID:24099030

  20. Bojito-Marrero L, Pyrsopoulos N. Hepatitis B and Hepatitis C Reactivation in the Biologic Era. J Clin Transl Hepatol. 2014 Dec;2(4):240-6. doi:10.14218/JCTH.2014.00033.  Epub 2014 Dec 15. Review.  PMID: 26355300

  21. Bojito-Marerro, L, Pyrsopoulos, NT. Hepatitis C Reactivation in the Biologic Era. Journal of Clinical and Translational Hepatology, 2014, Vol. 2: 240-246.

  22. Protopapas, G., Rao, K., Pyrsopoulos, NT. Management of Hepatitis C in the Pre- and Post-Transplant Setting: Then and Now. Gastroenterology & Hepatology: Open Access, September  2014 1(3):00019 – eISSN: 2373-6372

  23. Rodriguez S, Arrigo R, Pyrsopoulos N. An uncommon cause of gastrointestinal bleeding in patients with portal hypertension. Clin Gastroenterol Hepatol. 2014 Dec;12(12):A24 – PMID 25102444

  24. Madan SA, John F, Pyrsopoulos N, Pitchumoni CS. Nonalcoholic fatty liver disease and carotid artery atherosclerosis in children and adults: a meta-analysis.  .  Eur J Gastroenterol Hepatol. 2015 Nov;27(11):1237-48. doi: 10.1097/MEG.0000000000000429. Review.  PMID: 26193052

  25. Waller LP, Deshpande V, Pyrsopoulos N. Hepatocellular carcinoma: A comprehensive review. World J Hepatol. 2015 Nov 18;7(26):2648-63. doi: 10.4254/wjh.v7.i26.2648. Review.  Free PMC Article. – PMID 26609342

  26. Edula RG, Pyrsopoulos NT. New Methods of Testing and Brain Imaging in Hepatic Encephalopathy: A Review. Clin Liver Dis. 2015 Aug;19(3):449-59. doi: 10.1016/j.cld.2015.04.001. Epub 2015 May 23. Review.  PMID: 26195200

  27. Pievsky D, Pyrsopoulos N.Profile of tivantinib and its potential in the treatment of hepatocellular carcinoma: the evidence to date. J Hepatocell Carcinoma. 2016 Nov 15;3:69-76. eCollection 2016. Review. PMID:27896243

  28. Pyrsopoulos NT. Eosinophilic Esophagitis: A Comprehensive Review (2016) J Hepatol Gastroint Dis 2:122. doi:10.4172/jhgd.1000122 – PMID 26194940

  29. Gulati R, Nawaz M, Pyrsopoulos NT. Comparative analysis of online patient education material pertaining to hepatitis and its complications. Eur J Gastroenterol Hepatol. 2016 May;28(5):558- 66. doi: 10.1097/MEG.0000000000000588.  PMID: 26982338

  30. Kim HS, Patel KG, Orosz E, Kothari N, Demyen MF, Pyrsopoulos N, Ahlawat SK. Time Trends in the Prevalence of Celiac Disease and Gluten-Free Diet in the US Population: Results From the National Health and Nutrition Examination Surveys 2009-2014. JAMA Intern Med. 2016 Sep 6. doi: 10.1001/jamainternmed.2016.5254. [Epub ahead of print] PMID: 27598396

  31. Daclatasvir and Peginterferon/Ribavirin for Black/African-American and Latino Patients with HCV infection. Rodriguez-Torres M, Lawitz E, Yangco B, Jeffers L, Han SH, Thuluvath PJ, Rustgi V, Harrison S, Ghalib R, Vierling JM, Luketic V, Zamor PJ, Ravendhran N, Morgan TR, Pearlman B, O'Brien C, Khallafi H, Pyrsopoulos N, Kong G, McPhee F, Yin PD, Hughes E, Treitel M. 2016 Nov-Dec 2016 – PMID 27740516

  32. Yoon E, Babar A, Choudhary M, Kutner M, Pyrsopoulos N. Acetaminophen-Induced Hepatotoxicity: a Comprehensive Update. J Clin Transl Hepatol. 2016 Jun 28;4(2):131- 42. doi: 10.14218/JCTH.2015.00052. Epub 2016 Jun 15. Review.  PMID: 27350943

  33. Patel P, Schutzer SE, Pyrsopoulos N. Immunobiology of hepatocarcinogenesis: Ways to go or almost there? World J Gastrointest Pathophysiol. 2016 Aug 15;7(3):242-55. doi: 10.4291/wjgp.v7.i3.242. Review. PMID: 27574562

  34. Nneoma Okoronkwo, Nikolaos Pyrsopoulos. Comparison of Hepatocellular Carcinoma (HCC) tumor characteristics at diagnosis, management and outcomes in patients followed in a large academic liver center versus patients identified in the community. Submitted to Journal of clinical and translational Hepatology. 2017 Mar 28; 5(1): 31-34, PMID 28507924

  35. Rishabh Gulati, Mohammad Nawaz, Linh Lam, Nikolaos Pyrsopoulos. Comparative readability analysis of online patient education resources on Inflammatory Bowel Diseases. Canadian Journal of Gastroenterology and Hepatology. Volume 2017, Article ID 3681989, 9 pages. 2017 June 27 – PMID 28740843

  36. Phoenix Fung, Nikolaos Pyrsopoulos. Emerging Concepts in Alcoholic Liver Disease. World J Hepatol. 2017 Apr 28; 9(12): 567–585. – PMID 28515843

  37. Walker ND, Mourad Y, Liu K, Buxhoeveden M, Schoenberg C, Eloy JD, Wilson DJ, Brown LG, Botea A, Chaudhry F, Greco SJ, Ponzio NM, Pyrsopoulos N, Koneru B, Gubenko Y, Rameshwar P. Steroid-Mediated Decrease in Blood Mesenchymal Stem Cells in Liver Transplant could Impact Long-Term Recovery. Stem Cell Rev. 2017 Oct;13(5):644-658. doi: 10.1007/s12015-017-9751-3. – PMID 28733800

  38. Hyun-seok Kim, MD, MPH, Laura Rotundo, MD, Neil Kothari, MD, Sung-hoon Kim, KMD, PhD, Nikolaos Pyrsopoulos, MD, PhD, MBA Vitamin D is associated with severity and mortality of Non-Alcoholic Fatty Liver Disease in the United States. Prepared and ready for submission to Hepatology. 2017 Sep 28 – PMID 28936398

  39. Frenette CT, Morelli G, Shiffman ML, Frederick RT, Rubin RA, Fallon MB, Cheng JT, Cave M, Khaderi SA, Massoud O, Pyrsopoulos N, Park JS, Robinson JM, Yamashita M, Spada AP, Chan JL, Hagerty DT. Emricasan Improves Liver Function in Patients With Cirrhosis and High Model for End-stage Liver Disease Scores Compared With Placebo. 2018 Jun 15. Clin Gastroenterol Hepatol. 2018 Jun 15. pii: S1542-3565(18)30622-0. doi: 10.1016/j.cgh.2018.06.012 – PMID 29913280

  40. Garcia-Tsao G, Fuchs M, Shiffman M, Borg BB, Pyrsopoulos N, Shetty K, Gallegos-Orozco JF, Reddy KR, Feyssa E, Chan JL, Yamashita M, Robinson JM, Spada AP, Hagerty DT, Bosch J.  Emricasan (IDN-6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal Hypertension.2018 Jul 31 – PMID 30063802

  41. Bodek D, Patel P, Ahlawat S, Orosz E, Nasereddin T, Pyrsopoulos N. Superior Performance of Teaching and Transplant Hospitals in the Management of Hepatic Encephalopathy from 2007 to 2014. 2018 Dec 28 – PMID 30637212

  42. Edula RG, Muthukuru S, Moroianu S, Wang Y, Lingiah V, Fung P, Pyrsopoulos NT. CA-125 Significance in Cirrhosis and Correlation with Disease Severity and Portal Hypertension: A Retrospective Study.  2018 Sep 28 – PMID 30271734

  43. Pyrsopoulos, N. Acute Liver Failure. 2018 May 22. Volume 22 • Number 2 – PMID 29605077

  44. Patel, P., Okoronkwo, N., Pyrsopoulos, NT. Future Approaches and Therapeutic Modalities for Acute Liver Failure. Clin Liver Dis. 2018 May;22(2):419-427. doi: 10.1016/j.cld.2018.01.011. Epub 2018 Feb 9. – PMID 29605076

  45. Shen TD, Pyrsopoulos N, Rustgi VK. Microbiota and the liver. Liver Transpl. 2018 Apr;24(4):539-550. doi: 10.1002/lt.25008 – PMID 29316191

  46. Olivo R, Guarrera JV, Pyrsopoulos NT. Liver Transplantation for Acute Liver Failure. Clin Liver Dis. 2018 May;22(2):409-417. doi: 10.1016/j.cld.2018.01.014 – PMID 29605075

  47. Krawitz S, Lingiah V, Pyrsopoulos NT. Acute Liver Failure: Mechanisms of Disease and Multisystemic Involvement. Clin Liver Dis. 2018 May;22(2):243-256. doi: 10.1016/j.cld.2018.01.002. Epub 2018 Feb 9 – PMID 29605064

  48. Gulati R, Nawaz M, Pyrsopoulos NT. pHealth literacy and liver disease..Clin Liver Dis (Hoboken). 2018 Feb 28;11(2):48-51. doi: 10.1002/cld.690. eCollection 2018 Feb. Review. PMID: 30992787

  49. Pyrsopoulos N, Trilianos P, Lingiah VA, Fung P, Punnoose M. The safety and efficacy of ledipasvir/sofosbuvir with or without ribavirin in the treatment of orthotopic liver transplant recipients with recurrent hepatitis C: real-world data. . Eur J Gastroenterol Hepatol. 2018 Jul;30(7):761-765. – PMID 29481384

  50. Pievsky D, Rustgi N, Pyrsopoulos NT. Classification and Epidemiologic Aspects of Acute Liver Failure.. Clin Liver Dis. 2018 May;22(2):229-241. –PMID 29605063 

  51. Shah, J., Lingiah V, Pyrsopoulos N, Galan M. Acute Liver Injury in a Patient Treated With Rosuvastatin: A Rare Adverse Effect. 2019 Oct 12 – PMID 31636777

  52. Paterno F., Brown L., Wilson D, Pyrsopoulos N., Guarrera JV. Novel Arterial Reconstruction with Donor Femoral Artery in Split-Liver Transplantation. 2019 Oct 12 – PMID 31605654

  53. Leong K, Kuppasani K, Pyrsopoulos N. Atrial tumor thrombus: A rare complication of hepatocellular carcinoma. JAAPA. 2019 Feb; 32(2):23-26. PMID: 30694947

  54. Campo L, Eiseler S, Apfel T, Pyrsopoulos N. Fatty Liver Disease and Gut Microbiota: A Comprehensive Update. 2019 Mar 28 – PMID 30944821

  55. Piano S, Singh V, Caraceni P, Maiwall R, Alessandria C, Fernandez J, Soares EC, Kim DJ, Kim SE, Marino M, Vorobioff J, Barea RCR, Merli M, Elkrief L, Vargas V, Krag A, Singh SP, Lesmana LA, Toledo C, Marciano S, Verhelst X, Wong F, Intagliata N, Rabinowich L, Colombato L, Kim SG, Gerbes A, Durand F, Roblero JP, Bhamidimarri KR, Boyer TD, Maevskaya M, Fassio E, Kim HS, Hwang JS, Gines P, Gadano A, Sarin SK, Pyrsopoulos N, Angeli P; International Club of Ascites Global Study Group. Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide. 2019 April – PMID 30552895

  56. Younossi ZM, Ratziu V, Loomba R, Rinella M, Anstee QM, Goodman Z, Bedossa P, Geier A, Beckebaum S, Newsome PN, Sheridan D, Sheikh MY, Trotter J, Knapple W, Lawitz E, Abdelmalek MF, Kowdley KV, Montano-Loza AJ, Boursier J, Mathurin P, Bugianesi E, Mazzella G, Olveira A, Cortez-Pinto H, Graupera I, Pyrsopoulos N. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. 2019 Dec 14 – PMID 31813633

  57. C. Trilianos P., Tsangaris A., Tawadros A., Deshpande V., Pyrsopoulos N. The Reliability of Fibro-Test in Staging Orthotopic Liver Transplant Recipients with Recurrent Hepatitis. Journal of Clinical Translational Hepatology 2020 vol.8, 1-4 – eISSN 2310-8819

  58. Pyrsopoulos, NT, Charilaou, P. Inpatient Mortality Benefit with Transjugular Intrahepatic Portosystemic Shunt for Hospitalized Hepatorenal Syndrome Patients. Digestive Diseases and Sciences. DDSJ-D-19-02095R1